From the Department of Orthopaedic Surgery, Western University College of Osteopathic Medicine of the Pacific Northwest, Good Samaritan Regional Medical Center, Corvallis, OR (Tedesco), the Department of Orthopaedic Surgery, Case Western Reserve University Cleveland Clinic, Cleveland, OH (Mesko), and the University of Virginia School of Medicine - Inova Campus, Virginia Cancer Specialists, Fairfax, VA (Wodajo).

Correspondence to Dr. Tedesco: [email protected]

Dr. Tedesco or an immediate family member has stock or stock options held in Doctorpedia and RomTech; has received nonincome support (such as equipment or services), commercially derived honoraria, or other non–research-related funding (such as paid travel) from Medscape; serves as a board member, owner, officer, or committee member of Musculoskeletal Tumor Society; Editorial board: Journal of the American Osteopathic Academy of Orthopaedics. Dr. Mesko or an immediate family member serves as a paid consultant to Bone Support, ONKOS Surgical, and Stryker; is a member of a speakers’ bureau or has made paid presentations on behalf of Stryker and ONKOS Surgical; serves as a board member, owner, officer, or committee member of Musculoskeletal Tumor Society. Dr. Wodajo or an immediate family member serves as a paid consultant to ONKOS Surgical.

This clinical practice guideline was approved by the Musculoskeletal Tumor Society Executive Committee on April 12, 2023, and endorsed by the American Academy of Orthopaedic Surgeons on September 17, 2023.

The complete document, Management of Metastatic Humeral Disease, includes all tables, and figures, and is available at: https://www.orthoguidelines.org/topic?id=1045&tab=all_guidelines